Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(AJR American Journal of Roentgenology[TA])
26,323 results
  • Fetal Urinary Tract Anomalies: Review of Pathophysiology, Imaging, and Management. [Journal Article]
  • AAAJR Am J Roentgenol 2018 Feb 15; :1-12
  • Mileto A, Itani M, … Moshiri M
  • CONCLUSIONS: We provide an overview of common fetal anomalies of the kidneys and urinary tract with an emphasis on sonographic patterns as well as pathologic and postnatal correlation, along with brief recommendations for postnatal management. Of note, we render an updated classification of fetal abnormalities of the kidneys and urinary tract based on the presence or absence of associated urinary tract dilation. In addition, we review the 2014 classification of urinary tract dilation based on the Linthicum multidisciplinary consensus panel.
  • How to Integrate Cell-Free DNA Screening With Sonographic Markers for Aneuploidy: An Update. [Journal Article]
  • AAAJR Am J Roentgenol 2018 Feb 15; :1-7
  • Winter TC, Rose NC
  • CONCLUSIONS: The era of ultrasound markers as a screen for fetal aneuploidy is coming to a close. The detection of these markers on an ultrasound examination should simply serve as a reminder to ensure that the patient was offered cell-free DNA screening or conventional analyte screening. Cell-free DNA testing is revolutionizing screening. With normal results on a cell-free DNA test, many isolated soft markers-including CPCs, EIF, mild rhizomelic limb shortening, and mild pyelectasis-are irrelevant from a genetic standpoint. However, further counseling and workup are indicated for VM, true FEB, femur or humerus length measurement that is less than 2.5-percentile value, and pyelectasis to evaluate for the nongenetic associations with these findings. Finally, cell-free DNA testing is currently a screening test; positive results require definitive diagnostic testing with amniocentesis or chorionic villus sampling.
  • Colorectal Liver Metastasis: Overview of Treatment Paradigm Highlighting the Role of Ablation. [Journal Article]
  • AAAJR Am J Roentgenol 2018 Feb 15; :1-8
  • Venkat SR, Mohan PP, Gandhi RT
  • CONCLUSIONS: A randomized control trial of ablation combined with chemotherapy showed improved overall survival compared with chemotherapy alone. Local recurrence rates are comparable to those associated with resection when ablative margins of more than 5 mm are achieved and target lesions are smaller than 3 cm. In patients with unresectable disease, ablation for curative intent should be considered.
New Search Next